| Literature DB >> 30759802 |
Carmem Peres Valgas da Silva1,2, Diego Hernández-Saavedra3,4, Joseph D White5,6, Kristin I Stanford7,8.
Abstract
The rise in obesity over the last several decades has reached pandemic proportions. Brown adipose tissue (BAT) is a thermogenic organ that is involved in energy expenditure and represents an attractive target to combat both obesity and type 2 diabetes. Cold exposure and exercise training are two stimuli that have been investigated with respect to BAT activation, metabolism, and the contribution of BAT to metabolic health. These two stimuli are of great interest because they have both disparate and converging effects on BAT activation and metabolism. Cold exposure is an effective mechanism to stimulate BAT activity and increase glucose and lipid uptake through mitochondrial uncoupling, resulting in metabolic benefits including elevated energy expenditure and increased insulin sensitivity. Exercise is a therapeutic tool that has marked benefits on systemic metabolism and affects several tissues, including BAT. Compared to cold exposure, studies focused on BAT metabolism and exercise display conflicting results; the majority of studies in rodents and humans demonstrate a reduction in BAT activity and reduced glucose and lipid uptake and storage. In addition to investigations of energy uptake and utilization, recent studies have focused on the effects of cold exposure and exercise on the structural lipids in BAT and secreted factors released from BAT, termed batokines. Cold exposure and exercise induce opposite responses in terms of structural lipids, but an important overlap exists between the effects of cold and exercise on batokines. In this review, we will discuss the similarities and differences of cold exposure and exercise in relation to their effects on BAT activity and metabolism and its relevance for the prevention of obesity and the development of type 2 diabetes.Entities:
Keywords: 12,13-diHOME; FGF21; VEGF; brown adipose tissue; cold; exercise; glucose; lipids; obesity; phospholipids
Year: 2019 PMID: 30759802 PMCID: PMC6466122 DOI: 10.3390/biology8010009
Source DB: PubMed Journal: Biology (Basel) ISSN: 2079-7737
Figure 1Effects of cold exposure and exercise on BAT. (A) Exercise and (B) cold exposure effects on BAT metabolism can cause the release of batokines, which act in an autocrine, paracrine, or endocrine manner to influence metabolic health. (A) Exercise reduces insulin-stimulated glucose uptake in BAT, suppresses triglyceride (TAG) accumulation, and lowers mitochondrial lipids, such as cardiolipin (CL) and lysophosphatidylglycerol (LPG), which could affect the thermogenic capacity of BAT. Conversely, exercise training stimulates epoxide hydrolase 1 and 2 (Ephx1/2), and increases the synthesis of the lipokine 12,13-diHOME. The effects of exercise on mitochondrial activity, fibroblast growth factor 21 (FGF21) and vascular endothelial growth factor A (VEGFA) production are unknown. (B) Exposure to cold temperatures stimulates insulin-stimulated glucose uptake in BAT, synthesis of CL and LPG, and secretion of batokines FGF21 and VEGFA that lead to increased insulin sensitivity and tissue vascularization. Additionally, cold exposure increases the synthesis of 12,13-diHOME, which can act in an autocrine manner to promote fatty acid uptake in BAT, ultimately leading to increased TAG and UCP1-mediated thermogenesis.
Effect of cold and exercise on BAT metabolism in mice.
| Therapeutic Strategy | Reference | Treatment | Duration | Animal Model | Experimental Challenge | BAT Glucose Metabolism | BAT Lipid Metabolism | BAT Mitochondrial Activity |
|---|---|---|---|---|---|---|---|---|
|
| [ | 5 °C | 4 weeks | Rats | NA | NA | NA | ↑ Mitochondrial enzyme activity: cytochrome c; palmitoyl-CoA oxidase; catalase; acid phosphatase and peroxisomal activity |
|
| [ | −5 °C | 2 h/day 4 weeks | Rats | NE-induced thermogenesis | NA | ↑ BAT weight and lipid content | NA |
|
| [ | −15 °C | 2 h/day for 10 weeks | Rats | NA | ↑ BAT weight | NA | |
|
| [ | 5 °C | 48 h | Rats | 48 h fasting | ↑ 2-[3H]deoxyglucose uptake | NA | NA |
|
| [ | 4 °C | Acute: 4 h | Female Rats | 24 h fasting | Acute: | NA | NA |
|
| [ | 4 °C | 1 to 48 h | Mice | NA | ↑ Gene expression: PDH; PFK-C; PFK-1; GLUT4; LDH | ↑ Gene expression: ATP-citrate lyase; FAS; GPAT; ACC1; ACC2; LPL; MG lipase; LCAD; MCAD | NA |
|
| [ | 4 °C | 10 days | Rats | NA | NA | ↑ Glyceroneogenesis | NA |
|
| [ | 4 °C | 4 h | Female Rats | NA | ↑ 18F- or (3)H-FDG uptake | ↓ Lipid droplet size | ↑ UCP1 immunohistolocalization |
|
| [ | 4 °C | 5 weeks | Mice | NA | NA | ↓ Adipocyte size | ↑ Mitochondria number |
|
| [ | 4 °C | 24 h | Mice | NA | ↑ 14C-desoxyglucose uptake | ↑ BAT uptake of TRL | NA |
|
| [ | 4 °C | Acute and 3 weeks | UCP1-rtTA mice | Overexpression of VEGF-A | NA | NA | ↑ Mitochondrial |
|
| [ | 4 °C | 7, 14, and 21 days | Mice | NA | NA | ↓ Lipid droplet size | NA |
|
| [ | 4 °C | 4 h, 24 h, 48 h, and 72 h | Mice | NA | NA | ↑ Protein expression: PLIN1; PLIN2/ADRP; ATGL; HSL; pHSL | ↑ Protein expression: UCP1; CIDEA |
|
| [ | 4 °C | 0.5 to 10 days | AXB8 mice | NA | NA | NA | ↑ Protein expression: UCP1; COXIV; CYTC |
|
| [ | 4 °C | 3 days | Mice | NA | NA | ↑ Gene expression: LPL; LDLrap1; LRP5; Elovl3 | NA |
|
| [ | 4 °C | 1 to 7 days | Mice | NA | ↑GLUT1 gene expression (only days 1 and 2) | ↑ Protein expression: PPARγ; aP2 | ↑ Protein expression: UCP1 |
|
| [ | 4 °C | 24 h, 48 h, 96 h | Them1−/− and Them1+/+ mice | NA | NA | ↓ Triglyceride content | ↑ UCP1 Protein expression (96 h) |
|
| [ | 16 °C and 4 °C | 16 °C for 2 weeks and 4 °C for more than 2 weeks | WT, UCP1−/−, and SLN−/− mice | NA | NA | ↓ Lipid droplet size (WT and SLN−/−) | ↑ UCP1 imunohistolocalization |
|
| [ | 5 °C | 7 days | Mice | NA | NA | Remodeling of glycerophospholipids | ↑ Cardiolipins |
|
| [ | 5 °C | 3 h, 3 days, or 3 weeks | Mice | NA | ↑ Glucose metabolism signaling pathway | ↑ Signaling pathways: phospholipids metabolism; TAG biosynthesis; Glycerophospholipid biosynthesis; Fatty Acyl-CoA biosynthesis. | ↑ CRLS1 expression |
|
| [ | Treadmill training (25 m/min) | 4 weeks | Rats | Warm (24 °C) and cold acclimation (−5 °C, 2 h/day); All groups: NE-induced thermogenesis | NA | ↓ Lipid content in warm acclimated trained compared to warm-acclimated sedentary. | NA |
|
| [ | Treadmill training | 90 min/day | Male rats | NE stimulation | NA | NA | ↓ BAT Blood flow (but blood flow does not change between groups under NE stimulation) |
|
| [ | Swimming | 2 h/day for 10 weeks | Rats | NA | NA | ↓ BAT weight | NA |
|
| [ | Treadmill training | 6 weeks | Ovariectomized rats | NA | NA | NA | ↑ Mitochondrial protein content |
|
| [ | Swimming | 6 weeks | Male young and old mice | NA | NA | ↑ BAT weight | ↑ Mitochondrial protein content |
|
| [ | Swimming | 21 days | Rats | TSH-stimulation test | NA | NA | ↓ 5′ deiodinating activity |
|
| [ | Treadmill training (15 m/min) | 8 weeks | Chow diet mice and HFD mice | NA | NA | NA | ↑ UCP1 and Dio2 expression |
|
| [ | Swimming | 8 weeks | Ovariectomized rats | NA | NA | NA | ↑ Mitochondrial oxygen consumption |
|
| [ | Endurance (≈60% of VO2max), 5 days/week | 1 and 6 weeks. | Male Sprague Dawley rats | With or without recovery | No change in GLUT1 and 4 expression | ↑ Unilocular lipid droplet | ↑ PGC-1α and PGC-1β expression and weak UCP1 |
|
| [ | Treadmill training (70–85% VO2max | 8 weeks | Rats | NA | NA | ↑ Lipid droplet area. | ↓ Protein expression: UCP1; PGC1α |
|
| [ | Progressive treadmill training (18–25 m/min for 30–60 min at 10% incline) | 8 weeks | Male rats | NA | NA | ↑ Storage protein PLIN5 | No changes in mitochondrial proteins COX IV, PDH, UCP1 |
|
| [ | Wheel cage running | 3 weeks | Male mice | NA | NA | ↓ Fatty acid biosynthesis gene expression: Acaca; Scd1; Agpat3; Dgkd; Mlxipl | NA |
|
| [ | Treadmill training, 55–65% of maximal running speed (15–20 m/min) | 8 weeks | Rats | NA | ↑ Insulin signaling protein expression: IR; p-IRS-1; pERK | NA | ↑ Protein expression: NRF1; TFAM; PGC1α; SIRT1; pAMPK/AMPK ratio; ATP synthase; mMDH; UCP1; UCP2; UCP3 |
|
| [ | Swimming in low and moderate intensities | 13 weeks | Metabolic syndrome, high fat fed (30% lard) rats | NA | ↑ Akt-2 and GLUT4 gene expression | NA | NA |
|
| [ | Wheel cage running | 3 weeks | Mice | NA | ↑ Gene expression: GLUT4; Hk2; Eno1 | ↑ Gene expression: Fabp3; Acsl3; Gpd1; Gyk | ↑ Gene expression: Cidea; Cd36; Citrate synthase; UCP1 |
NA: Not available; PDH: Pyruvate dehydrogenase; PFK: Phosphofructokinase; LDH: Lactate dehydrogenase; FAS: Fatty Acid Synthase; GPAT: Glycerol-3-Phosphate Acyltransferase; ACC: Acetyl-CoA carboxylase; LPL: lipoprotein lipase; UCP1: mitochondrial uncoupling protein 1; MG: monoacylglycerol; LACD: Long-chain acyl-CoA dehydrogenase; MCAD: medium-chain acyl-CoA dehydrogenase; LCFA: Long-chain Fatty Acids; COX: Cytochrome c oxidase; AKT: RAC-alpha serine/threonine-protein kinase (PKB); CD36: cluster of differentiation 36; VEGF: Vascular endothelial growth factor; PLIN: Perilipin; ADRP: Adipose differentiation-related protein; ATGL: Adipose triglyceride lipase; HSL: Hormone-sensitive lipase; CIDEA: Cide domain-containing protein Cidea; PGC1α: Peroxisome proliferator-activated receptor gamma coactivator 1-alpha; CYTC: Cytochrome C; LDL: low-density lipoproteins; LRP: Lipoprotein receptor-related protein; ELOVL: Elongation of very long chain fatty acids protein; PPARγ: peroxisome proliferator-activated receptors gamma; WT: Wild Type; SLN: Sarcolipin; TFAM: Mitochondrial transcription factor A; CRLS: Cardiolipin Synthase; TCA: tricarboxylic acid cycle; ETC: electron transport chain; GDP: guanine diphosphate; TSH: Thyroid-stimulating hormone; HFD: High Fat Diet; Dio2: Type II iodothyronine deiodinase; MCT-1: Proton-linked monocarboxylate transporter, member 1; Acaca: Acetyl-CoA Carboxylase Alpha; Scd1: stearoyl-CoA desaturase 1; AGPAT: Acyl-CoA:glycerol-3-phosphate acyltransferase; Dgkd: Diacylglycerol kinase delta; Mlxipl: MLX-interacting protein-like; IR: Insulin Receptor; IRS: Insulin Receptor Substrate; ERK: extracellular signal–regulated kinase; NRF: Nuclear respiratory factor; SIRT1: Sirtuin 1; mMDH: Mitochondrial malate dehydrogenase; Hk2: Hexokinase 2; Eno1: Enolase 1; Fabp3: fatty acid-binding protein 3; Acsl3: Long-chain-fatty-acid—CoA ligase 3; Gpd1: Glycerol-3-phosphate dehydrogenase; Gyk: glycerokinase; NADH: Reduced Nicotinamide adenine dinucleotide.
Effect of cold and exercise on BAT metabolism in humans.
| Therapeutic Strategy | Reference | Treatment | Duration | Study Subjects | Experimental Challenge | Effects on Glucose Metabolism | Effects on Lipid Metabolism | Effects on BAT Mitochondrial Activity |
|---|---|---|---|---|---|---|---|---|
|
| [ | Cold outdoor weather in Northern Finland | NA | Male and female outdoor workers | NA | NA | NA | ↑ Enzyme activity: β-hydroxybutyrate dehydrogenase; Succinate dehydrogenase; Monoamine oxidase |
|
| [ | 16 °C | 2 h | Male | NA | ↑ 18F-FDG uptake | NA | NA |
|
| [ | 17 °C | 2 h | Male and female | Foot in cold water (5 min in/5 min out PET/CT session | ↑ 18F-FDG uptake | NA | NA |
|
| [ | 19 °C room and feet on an ice block intermittently (4 min every 5 min) | 1 h | Male and female | NA | ↑ 18F-FDG uptake | NA | NA |
|
| [ | 19 °C and were decreased by 1 °C approximately every 30 min until shivering. | 5−8 h | Male | NA | ↑ 18F-FDG uptake | NA | ↑UCP1 imunohistolocalization; |
|
| [ | 14 °C−15 °C | 10 days | Male T2DM subjects | NA | ↑ 18F-FDG uptake | NA | NA |
|
| [ | 18 °C | 2 h | Male T2DM | NA | NA | ↑ 18FTHA uptake | NA |
|
| [ | 19 °C and were decreased by 1 °C approximately every 30 min until subjects reported shivering | 6 h | Male | NA | ↑ 18F-FDG uptake | NA | NA |
|
| [ | 18 °C | 5−8 h | Male obese | NA | ↑ 18F-FDG uptake | ↑ LPL, CD36 gene expression. | ↑ UCP1gene expression |
|
| [ | 18°C | 5 h and 4 weeks | Male | NA | NA | ↑ DFA and 18FTHA uptake in acute stimulation; no further increase after chronic stimulation | NA |
|
| [ | Endurance-trained athletes | NA | Males | 2 h cold exposure | ↓ [18F]FDG uptake | NA | NA |
|
| [ | Athletes versus non-athletes | NA | Female | 14 °C for 120 min | Trend to ↓ [18F]FDG uptake | NA | NA |
|
| [ | HIIT and moderate continuous training | 2 weeks | Healthy middle-aged men | Insulin stimulated glucose uptake | No changes in glucose uptake | NA | NA |
NA: Not available; LPL: lipoprotein lipase; MG: monoacylglycerol; CD36: cluster of differentiation 36; UCP1: mitochondrial uncoupling protein 1; 18FTHA: 14(R, S)-[(18)F]Fluoro-6-thia-heptadecanoic acid; DFA: dietary fatty acids; HIIT: High-intensity interval training.